Literature DB >> 974127

Mechanism of hydroxylamine mutagenesis. Crystal structure and conformation of 1,5-dimethyl-N4-hydroxycytosine.

D Shugar, C P Huber, G I Birnbaum.   

Abstract

The crystal structure of the title compound, which is a formal analogue of 5-methyl-N4-hydroxycytosine nucleosides, has been determined by X-ray diffraction. The space group is P2(1)/c with a = 7.368 (2), b = 12.096 (3), c = 9.192 (4) A, beta = 113.94 (3) degrees. Three-dimensional intensity data were collected with a four-circle diffractometer, and the structure was refined by block-diagonal least-squares to R = 0.053. The compound is in the imino form, and the exocyclic N4-OH is located essentially in the plane of the pyrimidine ring, and syn to the ring (N(3). There is an intramolecular hydrogen bond involving the N(3)-H as donor and O(4) as acceptor, viz. N(3)-H(31)----O(4)-H. With this conformation, which probably prevails also in solution, the compound would be unable to participate in normal Watson-Crick base pairing. It is shown that a similar situation may prevail for N4-hydroxycytosine nucleosides. The implications with regard to the molecular mechanism of hydroxylamine mutagenesis, with particular reference to the T-even bacteriophages, are discussed. Analogous considerations are applied to an examination of the possible behaviour of hydroxylamine-modified adenine nucleosides.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 974127     DOI: 10.1016/0005-2787(76)90050-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Identification by UV resonance Raman spectroscopy of an imino tautomer of 5-hydroxy-2'-deoxycytidine, a powerful base analog transition mutagen with a much higher unfavored tautomer frequency than that of the natural residue 2'-deoxycytidine.

Authors:  W Suen; T G Spiro; L C Sowers; J R Fresco
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

2.  Polymerase recognition of synthetic oligodeoxyribonucleotides incorporating degenerate pyrimidine and purine bases.

Authors:  F Hill; D Loakes; D M Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

3.  Synthesis and duplex stability of oligonucleotides containing cytosine-thymine analogues.

Authors:  P K Lin; D M Brown
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

4.  Tautomerism and conformation of the promutagenic analogue N6-methoxy-2',3',5'-tri-O-methyladenosine.

Authors:  G I Birnbaum; B Kierdaszuk; D Shugar
Journal:  Nucleic Acids Res       Date:  1984-03-12       Impact factor: 16.971

5.  The stability of oligodeoxyribonucleotide duplexes containing degenerate bases.

Authors:  N N Anand; D M Brown; S A Salisbury
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

6.  Comparison of alkylation rates and mutagenicity of directly acting industrial and laboratory chemicals: epoxides, glycidyl ethers, methylating and ethylating agents, halogenated hydrocarbons, hydrazine derivatives, aldehydes, thiuram and dithiocarbamate derivatives.

Authors:  K Hemminki; K Falck; H Vainio
Journal:  Arch Toxicol       Date:  1980-12       Impact factor: 5.153

7.  Template properties of mutagenic cytosine analogues in reverse transcription.

Authors:  Tetsuya Suzuki; Kei Moriyama; Chie Otsuka; David Loakes; Kazuo Negishi
Journal:  Nucleic Acids Res       Date:  2006-11-27       Impact factor: 16.971

8.  N4-acyl-2'-deoxycytidine-5'-triphosphates for the enzymatic synthesis of modified DNA.

Authors:  Jevgenija Jakubovska; Daiva Tauraite; Lukas Birštonas; Rolandas Meškys
Journal:  Nucleic Acids Res       Date:  2018-07-06       Impact factor: 16.971

Review 9.  Epitope mapping: the first step in developing epitope-based vaccines.

Authors:  Jonathan M Gershoni; Anna Roitburd-Berman; Dror D Siman-Tov; Natalia Tarnovitski Freund; Yael Weiss
Journal:  BioDrugs       Date:  2007       Impact factor: 5.807

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.